Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith D Canby-Hagino

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Clinical Practice. Oncology|November 3, 2005
Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practiceEdith D Canby-Hagino, Ian M Thompson
Expert Opinion on Pharmacotherapy|April 26, 2006
Chemoprevention of prostate cancer with finasterideEdith D Canby-Hagino, Timothy C Brand, Javier Hernandez, et al.
The Journal of Urology|July 12, 2005
Prognostic features in men who died of prostate cancerKadee E Thompson, Javier Hernández, Edith D Canby-Hagino, et al.
Current Urology Reports|April 25, 2006
Prostate cancer detection strategiesTimothy C Brand, Javier Hernandez, Edith D Canby-Hagino, et al.
Current Urology Reports|May 5, 2005
Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?Edith D Canby-Hagino, Gregory P Swanson, E David Crawford, et al.
Hematology/Oncology Clinics of North America|July 25, 2006
Chemoprevention of prostate cancerTimothy C Brand, Edith D Canby-Hagino, A Pratap Kumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapyCarol M Moinpour, Katherine A Hayden, Joseph M Unger, et al.
Urology|March 6, 2012
Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109Ryan K Berglund, Catherine M Tangen, Isaac J Powell, et al.
The Journal of Urology|January 16, 2007
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomesMichael S Cookson, Gunnar Aus, Arthur L Burnett, et al.
The Journal of Urology|June 16, 2007
Erectile function outcome reporting after clinically localized prostate cancer treatmentArthur L Burnett, Gunnar Aus, Edith D Canby-Hagino, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Clinical Practice. Oncology|November 3, 2005
Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practiceEdith D Canby-Hagino, Ian M Thompson
Expert Opinion on Pharmacotherapy|April 26, 2006
Chemoprevention of prostate cancer with finasterideEdith D Canby-Hagino, Timothy C Brand, Javier Hernandez, et al.
The Journal of Urology|July 12, 2005
Prognostic features in men who died of prostate cancerKadee E Thompson, Javier Hernández, Edith D Canby-Hagino, et al.
Current Urology Reports|April 25, 2006
Prostate cancer detection strategiesTimothy C Brand, Javier Hernandez, Edith D Canby-Hagino, et al.
Current Urology Reports|May 5, 2005
Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?Edith D Canby-Hagino, Gregory P Swanson, E David Crawford, et al.
Hematology/Oncology Clinics of North America|July 25, 2006
Chemoprevention of prostate cancerTimothy C Brand, Edith D Canby-Hagino, A Pratap Kumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapyCarol M Moinpour, Katherine A Hayden, Joseph M Unger, et al.
Urology|March 6, 2012
Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109Ryan K Berglund, Catherine M Tangen, Isaac J Powell, et al.
The Journal of Urology|January 16, 2007
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomesMichael S Cookson, Gunnar Aus, Arthur L Burnett, et al.
The Journal of Urology|June 16, 2007
Erectile function outcome reporting after clinically localized prostate cancer treatmentArthur L Burnett, Gunnar Aus, Edith D Canby-Hagino, et al.
Pageof 1